SMA treatment is among the most expensive in the world. While government schemes like Ayushman Bharat and PMJAY provide limited coverage, they typically do not extend to gene therapy drugs like Zolgensma. Most families face a funding gap of ₹10 Crore or more — and time is critical.
ImpactGuru's platform has helped SMA families raise funds in as little as 72 hours.